Category: Exploring Adverse Events
Engage in meaningful discourse and gain valuable insights into the world of Adverse Events through our in-depth discussions and analyses.
-
Product Quality Complaints: An Adverse Event
This blog covers: Product Quality Complaint (PQC) A Product Quality Complaint (PQC) refers to any written, electronic, or oral communication alleging deficiencies related to a product’s identity, quality, durability, reliability, safety, effectiveness, or performance after its release and distribution in the market. This includes suspected medicine failures, damaged or missing products, incorrect strength or color,…
-
Disease Progression: A Special Case of Adverse Events
This article explores the concept of disease progression in pharmacovigilance, highlighting its distinction from other adverse events like Loss of Efficacy (LOE). It explains how disease progression reports can be handled.
-
No Adverse Event: A Comprehensive Overview
This comprehensive blog provides an in-depth look at what no adverse event reports are, while also addressing the uncertainties and scenarios you may encounter when handling these reports.
-
🍾 Misuse, Abuse & Addiction: An Adverse Event
In this comprehensive blog guide, we uncover the distinctions between misuse, abuse, and addiction as reported in pharmacovigilance, providing clear differentiations with relevant examples.
-
🤯 Occupational and Accidental Exposure: An Adverse Event
In this article, we address more complex special case scenarios, such as occupational and accidental exposures, when reported as adverse events.
-
📛 Medication Error: An Adverse Event
Discover crucial information on medication error and drug safety in Drugvigil’s blog. Stay informed on pharmacovigilance updates.
-
Off-Label Use: An Adverse Event
In this informative blog, you’ll explore into scenarios related to off-label use, learning how to assess them and accurately code them within MedDRA. Click to explore further details.
-
╰┈➤ Drug Interactions: An Adverse Event
In this comprehensive blog, we decode the conventions for assessing and coding drug interactions as adverse events in pharmacovigilance case processing. Click to learn more in detail.
